These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30633768)

  • 61. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V
    Bordachar P; Gras D; Clementy N; Defaye P; Mondoly P; Boveda S; Anselme F; Klug D; Piot O; Sadoul N; Babuty D; Leclercq C
    Heart Rhythm; 2018 Jun; 15(6):870-876. PubMed ID: 29288035
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heart Size Corrected Electrical Dyssynchrony and Its Impact on Sex-Specific Response to Cardiac Resynchronization Therapy.
    Salden OAE; van Stipdonk AMW; den Ruijter HM; Cramer MJ; Kloosterman M; Rienstra M; Maass AH; Prinzen FW; Vernooy K; Meine M
    Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008452. PubMed ID: 33296227
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Myocardial viability as shown by left ventricular lead pacing threshold and improved dyssynchrony by QRS narrowing predicts the response to cardiac resynchronization therapy.
    Takenaka M; Inden Y; Yanagisawa S; Fujii A; Ando M; Funabiki J; Murase Y; Otake N; Sakamoto Y; Shibata R; Murohara T
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):311-319. PubMed ID: 30516312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Bouchelouche K; Nielsen JC
    Trials; 2018 Nov; 19(1):600. PubMed ID: 30382923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
    Melo X; Abreu A; Santos V; Cunha P; Oliveira M; Pinto R; Carmo M; Fernhall B; Santa-Clara H
    Scand Cardiovasc J; 2019 Aug; 53(4):197-205. PubMed ID: 31221002
    [No Abstract]   [Full Text] [Related]  

  • 68. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Maximizing biventricular pacing in patients with rate-controlled atrial fibrillation using ventricular sense response.
    Montemezzo M; AlTurki A; Essebag V
    Pacing Clin Electrophysiol; 2019 Jul; 42(7):1069-1072. PubMed ID: 30828856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.
    Nakajima I; Noda T; Kanzaski H; Kamakura T; Wada M; Ishibashi K; Inoue Y; Miyamoto K; Okamura H; Nagase S; Aiba T; Kamakura S; Noguchi T; Yasuda S; Akashi YJ; Kusano KF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1227-1234. PubMed ID: 30236398
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
    Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
    J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac resynchronization therapy with His bundle pacing.
    Boczar K; Sławuta A; Ząbek A; Dębski M; Vijayaraman P; Gajek J; Lelakowski J; Małecka B
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):374-380. PubMed ID: 30659629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy.
    Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR
    JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay.
    Yeim S; Bordachar P; Reuter S; Laborderie J; O'Neill MD; Lafitte S; Deplagne A; Garrigue S; Roudaut R; Jais P; Haissaguerre M; Dossantos P; Clementy J
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):970-5. PubMed ID: 17669079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
    Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
    Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.